Health & Fitness News
FDA to Consider If Aleve Can Drop Heart Warning from Its Label
(NEW YORK) -- The Food and Drug Administration might soon give a common painkiller the right to drop a heart warning from its label -- a decision that could give it a big advantage over its competitors.
Aleve is advertised as the drug you can take less of, but until now, it and all other nonsteroidal anti-inflammatory drugs (NSAIDs) have come with warnings, saying they might hurt your heart.
Over the next two days, an FDA panel of experts will consider if Aleve should still carry that warning because the drug Naproxen, which is what Aleve really is, may not pose that risk.
If the panel says Aleve can lose the warning label and the FDA goes along, it could be a marketing boost worth billions of dollars.
Copyright 2014 ABC News Radio
See other Health news:Agency Releases First Data from National ALS Registry
Health Officials: Too Few Teens Receiving HPV Vaccines
Baby Who Can’t Open Mouth Celebrates First Birthday
CDC Lifts Moratorium on Shipment of Tuberculosis Samples
Cards Keep Pouring In for 5-Year-Old Boy Battling Cancer